KOSPI/KOSDAQ Market Close, Sep 28, 2026: KOSPI Loses 7,000 on U.S. Yields, HLB Lifts Biotech
Market Close · September 28, 2026
KOSPI fell 2.70% to 6,889.75 and slipped below 7,000 as the U.S. 10-year Treasury yield climbed to its highest level since 2007, while KOSDAQ edged up 0.25% on a biotech rally led by HLB's FDA approval. Here is what moved, why, and which parts of the supply chain the day's themes connect to.
| Index | Close | Change |
|---|---|---|
| KOSPI | 6,889.75 | -191.17 (-2.70%) |
| KOSDAQ | 846.58 | +2.10 (+0.25%) |
It was the first trading day after the Chuseok holiday. Foreign investors and institutions sold, and profit-taking hit the large chip names that had led the recent rally, including Samsung Electronics (KRX: 005930) and SK hynix (KRX: 000660).
What moved today
1. HLB group: FDA approval for Ripictu
Confirmed news. HLB (KOSDAQ: 028300) said its U.S. subsidiary Elevar Therapeutics received FDA approval for Ripictu (lirafugratinib), an FGFR2-targeted drug for previously treated advanced bile duct cancer. HLB group affiliates rose sharply, many near the daily limit. It is a different drug from the liver cancer combination HLB has pursued for years, which remains unapproved. Background: our HLB brief.
2. Digital healthcare and AI diagnostics
Sentiment spillover. The HLB news lifted drug and biotech sentiment broadly, and buying spread to AI diagnostics and digital health names such as 3billion and VUNO, alongside Lunit and Selvas Healthcare. There was no single company announcement driving this group; it moved on sector mood.
3. Obesity drugs: Korea BNC
Company-reported preclinical data. Korea BNC and ProApTek reported that their long-acting triple-agonist candidate (GLP-1, GIP and glucagon receptors) showed up to about 30% weight loss in animal studies. Korea BNC hit the daily limit. This is animal data; the companies plan further preclinical work before choosing a clinical candidate.
4. Glass substrates and PCBs
Market expectation, not confirmed adoption. As AI accelerators draw more power and need finer wiring, investors are again betting that chipmakers such as NVIDIA could move from organic to glass substrates in advanced packaging. Glass-substrate processing, inspection and equipment names rose, including JUSTEK, Hanbit Laser, Chemtronics, Philoptics and Tomocube. PCB and package-substrate makers such as Korea Circuit and Daeduck Electronics also gained on expectations of tight supply for high-layer AI server boards and FC-BGA substrates.
Supply-chain angle: the substrate is the layer that connects the chip package to the server board. Expectation of a shift in that layer moves the equipment makers first, before any customer or order is confirmed. We do not name any of these companies as an NVIDIA supplier; no such relationship was announced.
5. Solar
Price-driven rally. Reports of sharply higher U.S. solar module prices, tied to supply-chain restrictions and rising power demand including AI data centers, lifted Korean solar names such as Hanwha Solutions, OCI Holdings and HD Hyundai Energy Solutions.
6. Recent IPOs
Short-term money rotated among newly listed growth stocks, helped by the biotech mood.
Quick FAQ
Why did KOSPI fall today?
The U.S. 10-year yield rose to its highest level since 2007, and foreign and institutional investors took profits in large chip stocks such as Samsung Electronics and SK hynix.
Why did KOSDAQ rise when KOSPI fell?
KOSDAQ has a heavier weight in biotech, and HLB's FDA approval lifted the whole sector.
Has NVIDIA adopted glass substrates?
No announcement has been made. The rally in glass-substrate stocks reflects market expectation.
Sources: News1 closing reports for KOSPI and KOSDAQ (Sep 28, 2026), https://www.news1.kr/finance/market-exr/6303452 ; company announcements by HLB and Korea BNC as reported in Korean media.
This is our own summary and analysis, not a translation. It is not investment advice. See our Disclaimer and evidence labels.
Stock Anatomy · Last checked: September 28, 2026